Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C

NCT: NCT07662083 · NOT_YET_RECRUITING

NCT IDNCT07662083
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2027-07
SponsorWest Virginia University (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in adults with constipation-predominant irritable bowel syndrome (IBS-C). Participants will be randomized to receive either active or sham stimulation using a non-invasive auricular device over a 60-day period. The primary objectives are to assess changes in symptom severity and quality of life using validated instruments, including the IBS Symptom Severity Scale (IBS-SSS) and the IBS Quality of Life questionnaire (IBS-QOL). Secondary assessments include safety and participant compliance. This study aims to determine whether ta-VNS is an effective non-invasive therapeutic modality for improving symptoms and quality of life in patients with IBS-C.

Frequently Asked Questions

What is Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C?

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C is a clinical trial registered under NCT07662083. Current status: NOT_YET_RECRUITING.

What is the status of NCT07662083?

The current status of NCT07662083 (Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C) is: NOT_YET_RECRUITING.

When did Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C start?

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.